Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Livopick is an Ayurvedic herbal formulation developed by Wilson Drugs & Pharmaceuticals for the treatment and management of various liver disorders. Available in multiple dosage forms including tablets, capsules, syrup, and drops, Livopick is composed of a blend of traditional Indian medicinal herbs, including Bhringaraj (Eclipta alba), Bhumi Amla (Phyllanthus urinaria), Vaividang (Embelia ribes), Guduchi (Tinospora cordifolia), Sarpunkha (Tephrosia purpurea), Punarnava (Boerhavia diffusa), Kasni (Cichorium intybus), Kachur (Curcuma zedoaria), Kalmegh (Andrographis paniculata), and Harar (Terminalia chebula). These ingredients collectively provide hepatoprotective, antioxidant, anti-inflammatory, and mild laxative properties. Livopick is indicated for liver disorders, jaundice, infective hepatitis, loss of appetite, anorexia, constipation, and the side effects of alcoholism, helping to detoxify the liver, regularize bile secretion, and rejuvenate liver cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Livopick.